


































































Total(Window(2( I( 1.27( 2.09( 1.67(
Window"1" 13.08" 16.93" 16.31" 16.93"

















































2017( 2018( 2019( 2020( 2021(
Fund"Office" ""
"
4.00"" 4.00"" 4.00"" 4.00"" 4.00""
Consortium"Office" ""
"
6.60"" 6.60"" 6.60"" 6.60"" 6.60""
ISPC"(CGIAR"Fund"Financed"portion)"
"
2.33"" 2.33"" 2.33"" 2.33"" 2.33""
IEA" ""
"
3.94"" 3.94"" 3.94"" 3.94"" 3.94""
Trustee" ""
"
0.62"" 0.62"" 0.62"" 0.62"" 0.62""
Total(System(Entities'(costs( ((
"
17.49(( 17.49(( 17.49(( 17.49(( 17.49((
(( ((
" " " " " "Special(Initiatives(
" " " " " """"""Genebanks" ""
"
23.79"" 20.78" 16.50" 12.21" "8.72"    
Total(Systems(Cost(( ""
(
41.28(( 38.27(( 33.99(( 29.70(( 26.21((    
"" ""
" " " " " "




1000(( 1000(( 1000(( 1000(( 1000((    
(((((((((((((((CGIAR(Fund( 500(
" " " " " "
   
((((((((((((((((Bilateral(( 500(
" " " " " "
   
"" ""
" " " " " "
   
Cost(Sharing(Percentage( ((
"
4.13%( 3.83%( 3.39%( 2.97%( 2.62%(    
( ( " " " " " "
   
Assumptions:###
" " " " " " "
   
1.#Flat#budget#for#systems#entities#




















2017( 2018( 2019( 2020( 2021( Total(
Genebanks"budget" 30.54" 29.84" 28.03" 25.56" 23.75" 137.72"
Contribution"from"Endowment" 6.75" 9.06" 11.53" 13.35" 15.03" 55.72"
Contribution"from"CGIAR"Fund" 23.79" 20.78" 16.5" 12.21" 8.72" 82.00"
" " " " " " "Scenario(1(
" " " " " "Genebanks"Levy"at"2%" 20.00" 20.00" 20.00" 20.00" 20.00" 100.00"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 3.79" 0.78" (3.50)" (7.79)" (11.28)" (18.00)"
" " " " " " "Scenario(2(
" " " " " "Genebanks"Levy"at"1.5%" 15.00" 15.00" 15.00" 15.00" 15.00" 75.00"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 8.79" 5.78" 1.50" (2.79)" (6.28)" 7.00"
" " " " " " "Scenario(3(
" " " " " "Genebanks"Levy"at"1%" 10.00" 10.00" 10.00" 10.00" 10.00" 50.00"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 13.79" 10.78" 6.50" 2.21" (1.28)" 32.00"
" " " " " " "
" " " " " " "Notes:"

















2017( 2018( 2019( 2020( 2021( Total(
Genebanks"budget" 30.54" 29.84" 28.03" 25.56" 23.75" 137.72"
Contribution"from"Endowment" 6.75" 9.06" 11.53" 13.35" 15.03" 55.72"
Contribution"from"CGIAR"Fund" 23.79" 20.78" 16.50" 12.21" 8.72" 82.00"
" " " " " " "
" " " " " " "Scenario(1(
" " " " " "Genebanks"Levy"at"2%" 18.00" 18.00" 18.00" 18.00" 18.00" 90.00"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 5.79" 2.78" (1.50)" (5.79)" (9.28)" (8.00)"
" " " " " " "Scenario(2(
" " " " " "Genebanks"Levy"at"1.5%" 13.50" 13.50" 13.50" 13.50" 13.50" 67.50"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 10.29" 7.28" 3.00" (1.29)" (4.78)" 14.50"
" " " " " " "Scenario(3(
" " " " " "Genebanks"Levy"at"1%" 9.00" 9.00" 9.00" 9.00" 9.00" 45.00"
Balance"to"be"funded"by"(excess"
to"be"returned"to)"window"1" 14.79" 11.78" 7.50" 3.21" (0.28)" 37.00"
" " " " " " "
" " " " " " "Notes:"













































" 2017" 2018" 2019" 2020" 2021" Total"
All"options"–"projected"$m"from"Trust" 6.75" 9.06" 11.53" 13.35" 15.03" 55.72"
All"options"–"minimum"required"$m"from"
Fund"
23.79" 20.78" 16.50" 12.21" 8.72" 82.00"
" " " " " " "
Option(1(–(Increase(CSP( " " " " " "
New"CSP"%" 4.13" 3.83" 3.39" 2.97" 2.62" "
Option(2(–(Genebank(levy(1.5%1( " " " " " "
$m"balance"funded"by"W1/W2""
(or"excess"returned"to"W1)"
















Option(4(Plus(funding(GHUs( " " " " " "
Additional"cost"($m)" 2.22" 2.22" 2.22" 2.22" 2.22" 11.10"
Impact"on"Option"1" 4.35%" 4.05%" 3.62%" 3.19%" 2.84%" "
Impact"on"Option"2" 11.01" 8.00" 3.72" (0.57)" (4.06)" 18.10"
Impact"on"Option"3" 8.01" 5.00" 0.72" (3.57)" (7.06)" 3.10"
" " " " " " "
Option(5(–($5m(from(new(source3( " " " " " "
Impact"on"Option"1" 3.63%" 3.33%" 2.90%" 2.47%" 2.12%" "
Impact"on"Option"2" 3.79" 0.78" (3.50)" (7.79)" (11.28)" (18.00)"
Impact"on"Option"3" 0.79" (2.22)" (6.50)" (10.79)" (14.28)" (33.00)"
" " " " " " "
Option(6(–(Trust(eligibility(sooner( " " " " " "
Additional"cost"to"fund"($m)" 1.25" 1.25" 0" 0" 0" 2.50"
Revised"Trust"funding4" 6.75" 9.06" 13.35" 15.03" 16.71" 60.91"
Revised"required"from"fund" 25.04" 22.03" 13.00" 10.53" 7.04" 77.64"
" " " " " " "
Option(7(–(top(slice(W1(plus(W2( " " " " " "
Basic"required"from"fund" 23.79" 20.78" 16.50" 12.21" 8.72" 82.00"
Plus"option"4"additional"cost5" 26.01" 23.00" 18.72" 14.43" 10.94" 93.10"
Plus"option"5"new"resources6" 18.79" 15.78" 11.50" 7.21" 3.72" 57.00"
"
"
"
"
"
"""""""""""""""""""""""""""""""""""""""" """"""""""""""""""""
1"Based"on"$1"billion"total"annual"CGIAR"funding"
2"Based"on"$900m"total"annual"CGIAR"funding"
3"Guaranteed"%"or"amount"from"a"new"source"such"as"possible"RCF"
4"By"bringing"Trust"contributions"forward"by"one"year"starting"2019"
5"GHU"additional"cost"$2.22m/yr"
6"Additional"$5m/yr"from"innovative"source"e.g."RCF"
8"
"
Recommendations(
"
1. For"the"5"year"period"(2017\2021)"the"Fund"Council"should"commit"to"providing"a"minimum"
of"$82m"for"core"genebank"functions"[or"$93.1m"including"strengthened"Germplasm"Health"
Units.]"
"
2. Given"that"genebank"core"functions"are"fundamental"to"the"entire"CGIAR"research"effort,"all"
CGIAR"funders"should"contribute.""The"fairest"method,"to"avoid"free\riding,"is"to"apply"a"
specific"levy"to"all"funding"in"a"similar"fashion"to"the"current"CSP.""This"should"be"agreed"as"a"
matter"of"principle"(i.e."option"1,"adding"to"CSP,"is"not"recommended)."
"
3. The"level"of"the"levy"to"be"applied"should"be"set"for"a"period"of"5"years,"starting"in"2017.""This"
could"be"anywhere"between"1%"and"2%"depending"on"the"projected"total"CGIAR"funding,"
projected"Crop"Trust"contribution,"availability"of"resources"from"new"funding"mechanisms,"
and"any"W1"“top\up”"contribution"agreed"by"the"Fund"Council"(options"2"and"3)."
"
4. Strengthening"Germplasm"Health"Units"(GHUs)"should"be"accepted"as"an"integral"part"of"core"
genebank"functions"which"raises"the"cost"of"any"option"by"$2.22m/yr."(option"4)."
"
5. Tapping"into"new"funding"mechanisms"for"specific"contributions"for"genebanks"should"be"
built"in"where"appropriate"and"feasible"(option"5)"
"
6. Contingent"on"projections"of"Crop"Trust"contribution"availability,"additional"early"investment"
($2.5m)"in"upgrading"some"genebanks"to"make"them"eligible"for"Trust"funding"earlier"should"
be"considered"as"a"means"of"reducing"overall"costs"to"the"CGIAR"Fund.""(option"6"–"rough"
estimates"show"a"saving"of"$4.4m"for"an"investment"of"$2.5m)"
"
7. If"none"of"the"above"recommendations"are"deemed"acceptable,"PRT"recommends"that"the"
current"funding"mechanism"of"top\slicing"W1"to"make"up"for"W2"and"Crop"Trust"shortfalls"for"
genebank"core"functions"should"be"guaranteed"by"the"Fund"Council"in"order"to"ensure"
adequate"long"term"protection"and"rising"standards"of"CGIAR"genebanks"and"collections,"
recognising"that"this"recommendation"does"not"solve"the"free"riding"issue"(option"7)"
"
"
"
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